Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CMAX

CareMax (CMAX) Stock Price, News & Analysis

CareMax logo

About CareMax Stock (NASDAQ:CMAX)

Advanced Chart

Key Stats

Today's Range
$0.40
$0.54
50-Day Range
$0.42
$2.17
52-Week Range
$0.40
$8.49
Volume
893,330 shs
Average Volume
1.53 million shs
Market Capitalization
$1.61 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

CareMax, Inc. provides care and chronic disease management services through physicians and health care professionals. It offers a suite of health care and social services to its patients, including primary care, specialty care, telemedicine, health and wellness, optometry, dental, pharmacy, and transportation; and services to children and adults through Medicaid programs, as well as through commercial insurance plans. The company also provides CareOptimize, a proprietary software and services platform that provides data, analytics, and rules-based decision tools/workflows for physicians in the United States. It operates multi-specialty medical care centers in Florida, New York, Tennessee, and Texas. The company is headquartered in Miami, Florida.

Receive CMAX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CareMax and its competitors with MarketBeat's FREE daily newsletter.

CMAX Stock News Headlines

Warning echoes from the Great Depression
This is an urgent warning for All American investors … The current economic chaos is just a preview … What's coming next could be way scarier. In fact, in a matter of days, we could see a radical shift in the stock market … Companies who've been flying high could come crashing to Earth.
ClareMedica Health Partners To Buy CareMax's Core Centers' Assets
CareMax Seeks Restructuring Amid Chapter 11 Bankruptcy
See More Headlines

CMAX Stock Analysis - Frequently Asked Questions

CareMax, Inc. (NASDAQ:CMAX) released its quarterly earnings data on Monday, November, 15th. The company reported ($0.90) EPS for the quarter, topping the consensus estimate of ($9.90) by $9.00. The company earned $104.62 million during the quarter, compared to the consensus estimate of $110.99 million. CareMax had a negative net margin of 99.78% and a negative trailing twelve-month return on equity of 175.40%.

CareMax shares reverse split on Thursday, February 1st 2024. The 1-30 reverse split was announced on Thursday, February 1st 2024. The number of shares owned by shareholders was adjusted after the market closes on Thursday, February 1st 2024. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that CareMax investors own include Plug Power (PLUG), Workhorse Group (WKHS), FuelCell Energy (FCEL), Ovid Therapeutics (OVID), KALA BIO (KALA), Comtech Telecommunications (CMTL) and Fortress Biotech (FBIO).

Company Calendar

Last Earnings
11/15/2021
Today
5/10/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Nursing & personal care facilities
Sub-Industry
Healthcare
Current Symbol
NASDAQ:CMAX
Fax
N/A
Employees
1,450
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-683,350,000.00
Pretax Margin
-99.89%

Debt

Sales & Book Value

Annual Sales
$751.10 million
Price / Cash Flow
N/A
Book Value
$16.42 per share
Price / Book
0.03

Miscellaneous

Free Float
2,789,000
Market Cap
$1.61 million
Optionable
No Data
Beta
0.66
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

This page (NASDAQ:CMAX) was last updated on 5/10/2025 by MarketBeat.com Staff
From Our Partners